|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/13 | |
| A61P 31/14 | |||
| A61K 45/06 |
| (11) | Number of the document | 1797892 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06125649.1 |
| Date of filing the European patent application | 2004-09-02 | |
| (97) | Date of publication of the European application | 2007-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0320638 | 2003-09-03 | GB |
| (72) |
Hijikata, Makoto, JP
Shimotohno, Kunitada, JP
Watashi, Koichi, JP
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT |
| (54) | Use of modified cyclosporins for the treatment of HCV disorders |
| Use of modified cyclosporins for the treatment of HCV disorders |